New guidance from the NHS emphasizes the importance of ongoing check-ups for individuals stopping obesity medications like Wegovy and Mounjaro. The advice, provided by NICE, indicates that weight management should be viewed as a long-term process rather than a temporary solution, suggesting patients require additional support and strategies to maintain weight loss. Statistics reveal that approximately 240,000 people will receive Mounjaro in the next three years, while many individuals using these medications may not be eligible for NHS assistance as they pay privately. After discontinuing Wegovy, patients have been shown to regain two-thirds of the weight lost during treatment.
Successful weight management doesn't end when medication stops or when someone completes a behaviour change programme; it is a long-term journey that requires ongoing support.
People coming off obesity jabs like Wegovy and Mounjaro should have check-ups for at least a year to ensure they don't gain weight back.
Collection
[
|
...
]